JP2024535745A5 - - Google Patents
Info
- Publication number
- JP2024535745A5 JP2024535745A5 JP2024514006A JP2024514006A JP2024535745A5 JP 2024535745 A5 JP2024535745 A5 JP 2024535745A5 JP 2024514006 A JP2024514006 A JP 2024514006A JP 2024514006 A JP2024514006 A JP 2024514006A JP 2024535745 A5 JP2024535745 A5 JP 2024535745A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- hydrogen
- oxo
- group
- thiadiazolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2112529.9A GB202112529D0 (en) | 2021-09-02 | 2021-09-02 | New compounds |
| GB2112529.9 | 2021-09-02 | ||
| PCT/GB2022/052234 WO2023031609A1 (en) | 2021-09-02 | 2022-09-01 | Thiadiazolone derivatives useful as ampk activator |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535745A JP2024535745A (ja) | 2024-10-02 |
| JP2024535745A5 true JP2024535745A5 (enExample) | 2025-09-05 |
Family
ID=78076730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024514006A Pending JP2024535745A (ja) | 2021-09-02 | 2022-09-01 | Ａｍｐｋ活性化剤として有用なチアジアゾロン誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250136563A1 (enExample) |
| EP (1) | EP4396171A1 (enExample) |
| JP (1) | JP2024535745A (enExample) |
| KR (1) | KR20240055039A (enExample) |
| CN (1) | CN118510762A (enExample) |
| AU (1) | AU2022336441A1 (enExample) |
| CA (1) | CA3230307A1 (enExample) |
| GB (1) | GB202112529D0 (enExample) |
| IL (1) | IL310871A (enExample) |
| MX (1) | MX2024002674A (enExample) |
| WO (1) | WO2023031609A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3075388T3 (en) | 2019-10-18 | 2026-08-04 | Betagenon Ab | New formulations |
| GB202015585D0 (en) | 2020-10-01 | 2020-11-18 | Betagenon Bio Ab | New compounds |
| WO2025252672A1 (en) * | 2024-06-03 | 2025-12-11 | Betagenon Ab | Use of tryptophan and metabolites thereof as biomarkers for treatment methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200720264A (en) * | 2005-04-25 | 2007-06-01 | Lundbeck & Co As H | Pro-drugs of n-thiazol-2-yl-benzamide derivatives |
| US20090156644A1 (en) * | 2005-07-21 | 2009-06-18 | Jacob Westman | Use of thiazole derivatives and analogues in the treatment of cancer |
| AU2010270030B2 (en) * | 2009-07-08 | 2015-12-24 | Baltic Bio Ab | 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer |
| JP2013230986A (ja) * | 2010-08-25 | 2013-11-14 | Kyorin Pharmaceutical Co Ltd | 新規ヒダントイン誘導体及びそれらを有効成分とする医薬 |
| KR101889993B1 (ko) * | 2010-09-10 | 2018-08-20 | 시오노기세야쿠 가부시키가이샤 | Ａｍｐｋ 활성화 작용을 갖는 헤테로환 축합 이미다졸 유도체 |
| WO2013108026A1 (en) * | 2012-01-17 | 2013-07-25 | Baltic Bio Ab | Thiadiazolone derivatives useful in the treatment of diabetes |
| CN111848579B (zh) * | 2019-04-26 | 2023-11-14 | 君实润佳(上海)医药科技有限公司 | 4-(2,6-二氯苯甲酰氨基)-n-(4-哌啶基)-1h-吡唑-3-甲酰胺的前药 |
| GB202015585D0 (en) * | 2020-10-01 | 2020-11-18 | Betagenon Bio Ab | New compounds |
-
2021
- 2021-09-02 GB GBGB2112529.9A patent/GB202112529D0/en not_active Ceased
-
2022
- 2022-09-01 US US18/684,154 patent/US20250136563A1/en active Pending
- 2022-09-01 AU AU2022336441A patent/AU2022336441A1/en active Pending
- 2022-09-01 MX MX2024002674A patent/MX2024002674A/es unknown
- 2022-09-01 WO PCT/GB2022/052234 patent/WO2023031609A1/en not_active Ceased
- 2022-09-01 CN CN202280073480.7A patent/CN118510762A/zh active Pending
- 2022-09-01 JP JP2024514006A patent/JP2024535745A/ja active Pending
- 2022-09-01 CA CA3230307A patent/CA3230307A1/en active Pending
- 2022-09-01 KR KR1020247010453A patent/KR20240055039A/ko active Pending
- 2022-09-01 EP EP22792860.3A patent/EP4396171A1/en active Pending
- 2022-09-01 IL IL310871A patent/IL310871A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4450620B2 (ja) | メラノコルチンレセプターリガンドとしてのｎ−フェニルピロールグアニジン誘導体 | |
| CN1113066C (zh) | 新型肽衍生物 | |
| TWI226331B (en) | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | |
| JP5105297B2 (ja) | Ｐｐａｒ活性調節剤 | |
| JP2005518350A5 (enExample) | ||
| JP2023512501A5 (enExample) | ||
| WO2011134284A1 (zh) | 胰高血糖素样肽-1类似物及其应用 | |
| JP2009505962A5 (enExample) | ||
| CN1622805A (zh) | 包含止泻药和埃坡霉素或埃坡霉素衍生物的组合 | |
| CN102387704A (zh) | S1p5受体的激动剂和拮抗剂，和其用法 | |
| JPH05246968A (ja) | ケトン誘導体 | |
| JP7854780B2 (ja) | 核内受容体に対して活性の化合物 | |
| EP2268652A2 (fr) | Dérivés platine - carbene n-heterocyclique, leur préparation et leur application en thérapeutique | |
| JP2018519244A (ja) | ピロリジンカルボキサミド誘導体ならびにその調製および使用方法 | |
| US20110230479A1 (en) | Neurotrophin mimetics and uses thereof | |
| JPH06192199A (ja) | ケトン誘導体 | |
| JP2024535745A (ja) | Ａｍｐｋ活性化剤として有用なチアジアゾロン誘導体 | |
| CN88103735A (zh) | 新的吡唑啉衍生物及以该化合物为活性成份治疗脑血管疾病的药物 | |
| CN102203130B (zh) | Glp-1衍生物及其应用 | |
| EP3789389B1 (en) | Crystalline form of (s)-n-[5-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-4,6-dioxo-5,6-dihydro-4h-thieno[3,4-c]pyrrole-1-yl]acetamide | |
| JP4817281B2 (ja) | パーキンソン病治療剤 | |
| CN1169721A (zh) | 吡啶衍生物 | |
| CN103827100B (zh) | 用于降低血清尿酸的[1,2,4]噻二嗪1,1-二氧化物化合物 | |
| JP5871905B2 (ja) | グルカゴン様ペプチド−１類似体およびその使用 | |
| CN101768133A (zh) | 二苯基乙烯类衍生物及其用途 |